BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24154931)

  • 1. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The United States' Federal Parity Act and treatment of substance use disorders: Administrators' familiarity and perceptions of impact.
    Edmond MB; Aletraris L; Roman PM; Fields DL; Bride BE
    Int J Drug Policy; 2016 Aug; 34():80-7. PubMed ID: 27450320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance expansions and adolescent use of substance use disorder treatment.
    Hamersma S; Maclean JC
    Health Serv Res; 2021 Apr; 56(2):256-267. PubMed ID: 33210305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Litigation Provides Clues to Ongoing Challenges in Implementing Insurance Parity.
    Berry KN; Huskamp HA; Goldman HH; Rutkow L; Barry CL
    J Health Polit Policy Law; 2017 Dec; 42(6):1065-1098. PubMed ID: 28801470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit requirements for substance use disorder treatment in state health insurance exchanges.
    Tran Smith B; Seaton K; Andrews C; Grogan CM; Abraham A; Pollack H; Friedmann P; Humphreys K
    Am J Drug Alcohol Abuse; 2018; 44(4):426-430. PubMed ID: 29261341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Oregon's parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services.
    McConnell KJ; Ridgely MS; McCarty D
    Drug Alcohol Depend; 2012 Aug; 124(3):340-6. PubMed ID: 22382046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of federal parity on substance use disorder treatment.
    Busch SH; Epstein AJ; Harhay MO; Fiellin DA; Un H; Leader D; Barry CL
    Am J Manag Care; 2014; 20(1):76-82. PubMed ID: 24512166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral health insurance parity: does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act?
    McConnell KJ; Gast SH; Ridgely MS; Wallace N; Jacuzzi N; Rieckmann T; McFarland BH; McCarty D
    Am J Psychiatry; 2012 Jan; 169(1):31-8. PubMed ID: 21890792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders.
    Aletraris L; Edmond MB; Roman PM
    J Psychoactive Drugs; 2017; 49(2):141-150. PubMed ID: 28406363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?
    Friedman SA; Azocar F; Xu H; Ettner SL
    Drug Alcohol Depend; 2018 Sep; 190():151-158. PubMed ID: 30032052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review.
    Jacob V; Qu S; Chattopadhyay S; Sipe TA; Knopf JA; Goetzel RZ; Finnie R; Thota AB;
    J Ment Health Policy Econ; 2015 Mar; 18(1):39-48. PubMed ID: 25862203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Does Mental Health Parity Really Mean for the Care of People with Serious Mental Illness?
    Bartlett J; Manderscheid R
    Psychiatr Clin North Am; 2016 Jun; 39(2):331-42. PubMed ID: 27216906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
    Dave D; Mukerjee S
    Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures.
    Barry CL; Chien AT; Normand SL; Busch AB; Azzone V; Goldman HH; Huskamp HA
    Pediatrics; 2013 Mar; 131(3):e903-11. PubMed ID: 23420919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage mandates and market dynamics: employer, insurer and patient responses to parity laws.
    Nathenson RA
    Health Econ Policy Law; 2020 Apr; 15(2):173-195. PubMed ID: 30309399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal Parity and Access to Behavioral Health Care in Private Health Plans.
    Hodgkin D; Horgan CM; Stewart MT; Quinn AE; Creedon TB; Reif S; Garnick DW
    Psychiatr Serv; 2018 Apr; 69(4):396-402. PubMed ID: 29334882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.